Related Experiment Videos
Working party: management of hepatitis B carriers
The New Zealand Medical Journal
|February 13, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Establishing a baseline for a national paediatric antimicrobial stewardship programme.
The Journal of antimicrobial chemotherapy·2019
The eastern extent of seasonal iron limitation in the high latitude North Atlantic Ocean.
Scientific reports·2019
Results from the third Scottish National Prevalence Survey: is a population health approach now needed to prevent healthcare-associated infections?
The Journal of hospital infection·2018
Oxidative costs of reproduction: Oxidative stress in mice fed standard and low antioxidant diets.
Physiology & behavior·2015
Publicly funded healthcare, social insurance and justice in Aotearoa New Zealand.
The New Zealand medical journal·2026
Drilling a hole to shorten the gap: an Aotearoa New Zealand therapeutic algorithm for status epilepticus in NEUROPA (Madrid, Spain).
The New Zealand medical journal·2026
The impact of New Zealand's 2018 methamphetamine policy on residential contamination.
The New Zealand medical journal·2026
The Deterioration Early Warning System for aged residential care: a feasibility study with qualitative analysis.
The New Zealand medical journal·2026
Hand grip strength and future hospitalisations in Māori and non-Māori New Zealand octogenarians: the LiLACS NZ cohort study.
The New Zealand medical journal·2026
Fractional exhaled nitric oxide is a non-invasive disease activity marker of IgG4-related disease.
Rheumatology (Oxford, England)·2026
Coronary CT angiography-derived perivascular fat attenuation index as a potential marker for heart failure in hypertrophic cardiomyopathy.
The British journal of radiology·2026
One-Step Immobilized Phage Depolymerase Coatings for Catheter-Related Bloodstream Infections.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Inhibition of Dyrk1a attenuates type 1 diabetic cardiomyopathy via anti‑ferroptosis.
Molecular medicine reports·2026